NYSE:AET - Aetna Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week Range$166.88 - $213.36
VolumeN/A
Average Volume3.69 million shs
Market Capitalization$69.64 billion
P/E Ratio21.57
Dividend Yield0.94%
Beta0.71
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.

Receive AET News and Ratings via Email

Sign-up to receive the latest news and ratings for AET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP00817Y10
Phone860-273-0123

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$60.54 billion
Book Value$56.70 per share

Profitability

Net Income$1.90 billion

Miscellaneous

EmployeesN/A
Market Cap$69.64 billion
Next Earnings DateN/A
OptionableOptionable

Aetna (NYSE:AET) Frequently Asked Questions

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna declared a quarterly dividend on Friday, September 28th. Stockholders of record on Wednesday, October 24th will be paid a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 dividend on an annualized basis and a dividend yield of ∞. The ex-dividend date of this dividend is Tuesday, October 23rd. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna declared that its board has initiated a share buyback plan on Friday, April 7th 2017, which authorizes the company to buyback $4,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 98% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's board of directors believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna Inc (NYSE:AET) announced its quarterly earnings results on Tuesday, October, 30th. The company reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.83 by $0.13. The company earned $15.48 billion during the quarter, compared to analyst estimates of $15.40 billion. Aetna had a return on equity of 20.78% and a net margin of 5.99%. The business's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period last year, the business earned $2.45 EPS. View Aetna's Earnings History.

What price target have analysts set for AET?

4 analysts have issued 1 year price objectives for Aetna's stock. Their predictions range from $204.00 to $206.00. On average, they expect Aetna's share price to reach $205.25 in the next twelve months. View Analyst Price Targets for Aetna.

What is the consensus analysts' recommendation for Aetna?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aetna in the last year. There are currently 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Aetna.

What are Wall Street analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:
  • 1. According to Zacks Investment Research, "Shares of Aetna have outperformed the industry's growth in six months. Moreover, it has witnessed its 2018 earnings move upward over the past seven days. The recent sale of its U.S. Group Life and Disability business will enable the company to focus on its core growth areas. It is on track to be acquired by CVS Health and has announced that it will sell Medicare Part D business. The DoJ's approval takes the deal toward closure, which is scheduled in the fourth quarter of 2018. Its revenues suffered a decline in 2017, improved in the first nine months of 2018 but should remain subdued in the coming quarters. Declining membership and rising expenses are some other concerns." (11/28/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on AET shares and increase our price target to $204 from $202 previously. Our price target is based on the implied CVS Health (CVS – Not Covered) acquisition value. BMO on Tuesday, October 30, AET reported 3Q18 results. Adjusted EPS were exactly in line with our estimate but nicely above FactSet consensus. Revenue was slightly below our estimate but above consensus. MLR was above our estimate and consensus. Operating expenses offset the increase in MLR, relative to ur estimate. As reminder, the company has not provided 2018 guidance given the pending CVS merger." (10/30/2018)

Has Aetna been receiving favorable news coverage?

News articles about AET stock have trended neutral recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Aetna earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the near term.

Who are some of Aetna's key competitors?

What other stocks do shareholders of Aetna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aetna investors own include Netflix (NFLX), Gilead Sciences (GILD), Walt Disney (DIS), Boeing (BA), Home Depot (HD), Visa (V), UnitedHealth Group (UNH), JPMorgan Chase & Co. (JPM), Bank of America (BAC) and NVIDIA (NVDA).

Who are Aetna's key executives?

Aetna's management team includes the folowing people:
  • Mr. Mark Thomas Bertolini, Chairman & CEO (Age 61)
  • Ms. Karen Sue Lynch, Pres (Age 55)
  • Mr. Shawn Michael Guertin, Exec. VP, CFO & Chief Enterprise Risk Officer (Age 54)
  • Mr. Richard Michael Jelinek, Exec. VP and Head of Enterprise Strategy & Integration (Age 52)
  • Ms. Margaret M. McCarthy, Exec. VP of Operations & Technology (Age 64)

Who are Aetna's major shareholders?

Aetna's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Curbstone Financial Management Corp (0.00%) and Curbstone Financial Management Corp (0.00%). Company insiders that own Aetna stock include Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Which institutional investors are buying Aetna stock?

AET stock was bought by a variety of institutional investors in the last quarter, including Curbstone Financial Management Corp and Curbstone Financial Management Corp. View Insider Buying and Selling for Aetna.

How do I buy shares of Aetna?

Shares of AET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is Aetna?

Aetna has a market capitalization of $0.00 and generates $60.54 billion in revenue each year. The company earns $1.90 billion in net income (profit) each year or $9.86 on an earnings per share basis.

What is Aetna's official website?

The official website for Aetna is http://www.aetna.com.

How can I contact Aetna?

Aetna's mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company can be reached via phone at 860-273-0123 or via email at [email protected]


MarketBeat Community Rating for Aetna (NYSE AET)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  867 (Vote Outperform)
Underperform Votes:  674 (Vote Underperform)
Total Votes:  1,541
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe AET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Featured Article: What are gap-up stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel